A Pilot Study Of A Novel Treatment Regimen, Maraviroc + Ritonavir Boosted Atazanavir, In Treatment Naive HIV-Infected Patients

NCT00827112 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Immunodeficiency Virus-1

Interventions

DRUG: maraviroc
DRUG: maraviroc

Sponsor

ViiV Healthcare

Collaborators

[object Object]